Clinical Trial Update: Dopaminergic Disruption Induced by Traumatic Coma: Dopaminergic Pathways Abnormalities and Biomarkers of Recovery Using MRI and 18F-LBT-999 PET [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in France investigating dopaminergic disruption after traumatic coma, using MRI and 18F-LBT-999 PET to study pathway abnormalities and bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coma
• Traumatic Brain Injury

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Coma, Traumatic | Phase 2 | Status: RECRUITING